Cybin (HELP) Long-Term Investments (2021 - 2022)
Cybin (HELP) posted quarterly Long-Term Investments of $92087.9 for Q4 2022, down 53.57% year-on-year from $198334.0 in Q4 2021, and down 56.8% on a QoQ basis from $213155.5 in Q3 2022.
Cybin (HELP) Long-Term Investments (2021 - 2022) Analysis & Trends
Cybin (HELP) has reported Long-Term Investments for 2 consecutive years, with $92087.9 the latest figure, recorded in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 92,087.87 |
| Sep 30, 2022 | 213,155.46 |
| Dec 31, 2021 | 198,334.02 |
| Sep 30, 2021 | 198,602.33 |
| Jun 30, 2021 | 203,381.79 |